Paratek Pharmaceuticals Inc (PRTK) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Paratek Pharmaceuticals Inc   (NASDAQ: PRTK)


Paratek Pharmaceuticals Inc 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Paratek Pharmaceuticals Inc 's ROA in the first quarter of 2023?
Paratek Pharmaceuticals Inc recorded a cumulative net loss of $-66 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -40.87%.

However, within the Healthcare sector 628 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 4556, from total ROA ranking in the fourth quarter of 2022 at 5196.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Total Assets Change -11.59 % -6.09 % -13.72 % -8.7 % 6.83 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -66 -64 -89 -86 -59
Return On Assets (TTM) -40.87 % -38.31 % -52.55 % -49.14 % -32.79 %
PRTK's Total Ranking # 4556 # 5196 # 4909 # 5007 # 4673
Total Assets (TTM) in million 150 173 157 164 170
Seq. Total Assets Change -12.81 % 9.67 % -3.89 % -3.8 % -7.38 %
Seq. Net Income Change - - - - -

PRTK's 5 Years Annual ROA >> Back to PRTK Management Effectiveness >> Compare PRTK ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 263
Sector # 629
Overall # 4462

Return On Assets Statistics
High Average Low
15.91 %
-45.98 %
-81.15 %
(Sep. 30, 2015)   (Dec 31 2016)





Financial Statements
Paratek Pharmaceuticals Inc 's Assets $ 150 million PRTK's Balance sheet
Paratek Pharmaceuticals Inc 's Income $ -20 million Quarterly PRTK's Income Statement
PRTK's Income by Division See PRTK's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -6.09 % 4.44 % -29.94 % -16.36 % 83.38 %
Total Assets in million 173 184 176 251 300
Y / Y Net Income Change - - - - -
Net Income in million -64 -59 -97 -129 -112
Annual Return On Assets -36.84 % -32.16 % -54.88 % -51.29 % -37.43 %

PRTK's 5 Years Annual ROA >> Back to PRTK Management Effectiveness >> Compare PRTK ROA to its Competitors



More Return On Assets Ratios
PRTK's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PRTK's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PRTK's Competitors
Subscribers only: Roa for Paratek Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for PRTK's Customers

You may also want to know
PRTK's Roi PRTK's Inventory Turnover Ratio PRTK's Growth Rates PRTK's Dividend Comparisons
PRTK's Profitability Ratios PRTK's Asset Turnover Ratio PRTK's Dividend Growth
PRTK's Roe PRTK's Valuation Ratios PRTK's Financial Strength Ratios PRTK's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:56+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.